Phase 2 study of pembrolizumab in patients with advanced rare cancers

Aung Naing; Funda Meric-Bernstam; Bettzy Stephen; Daniel D Karp; Joud Hajjar; Jordi Rodon Ahnert; Sarina A Piha-Paul; Rivka R Colen; Camilo Jimenez; Kanwal P Raghav; Renata Ferrarotto; Shi-Ming Tu; Matthew Campbell; Linghua Wang; Sarjeel H Sabir; Coya Tapia; Chantale Bernatchez; Michael Frumovitz; Nizar Tannir; Vinod Ravi; Saria Khan; Jeane M Painter; Abulrahman Abonofal; Jing Gong; Anas Alshawa; Lacey M McQuinn; Mingxuan Xu; Sara Ahmed; Vivek Subbiah; David S Hong; Shubham Pant; Timothy A Yap; Apostolia M Tsimberidou; Ecaterina E Ileana Dumbrava; Filip Janku; Siqing Fu; Richard M Simon; Kenneth R Hess; Gauri R Varadhachary; Mouhammed Amir Habra

doi:10.1136/jitc-2019-000347

Article info

This article has a correction. Please see:

Correction: Phase 2 study of pembrolizumab in patients with advanced rare cancers - April 01, 2020

PDF

XML

Clinical/translational cancer immunotherapy

Original research

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Authors

Aung Naing Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Funda Meric-Bernstam Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Bettzy Stephen Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Daniel D Karp Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Joud Hajjar Section of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA PubMed articles Google scholar articles
Jordi Rodon Ahnert Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Sarina A Piha-Paul Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Rivka R Colen Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Camilo Jimenez Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Kanwal P Raghav Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Renata Ferrarotto Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Shi-Ming Tu Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Matthew Campbell Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Linghua Wang Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Sarjeel H Sabir Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Coya Tapia Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Chantale Bernatchez Melanoma Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Michael Frumovitz Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Nizar Tannir Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Vinod Ravi Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Saria Khan Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Jeane M Painter Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Abulrahman Abonofal Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Jing Gong Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Anas Alshawa Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Lacey M McQuinn Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Mingxuan Xu Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Sara Ahmed Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Vivek Subbiah Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
David S Hong Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Shubham Pant Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Timothy A Yap Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Apostolia M Tsimberidou Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Ecaterina E Ileana Dumbrava Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Filip Janku Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Siqing Fu Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Richard M Simon R Simon Consulting, Potomac, Maryland, USA PubMed articles Google scholar articles
Kenneth R Hess Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Gauri R Varadhachary Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Mouhammed Amir Habra Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles

Citation

Naing A, Meric-Bernstam F, Stephen B, et al

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer 2020;8:e000347. doi: 10.1136/jitc-2019-000347

Online issue publication

January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password